We use cookies to enhance your browsing experience, analyze website traffic, and maintain essential site functionality. By clicking "Accept All", you consent to our use of cookies. For more details, please review our Privacy Policy.

Bioventus Stock (NASDAQ:BVS)



Previous Close

$10.42

52W Range

$3.90 - $14.38

50D Avg

$10.54

200D Avg

$9.32

Market Cap

$680.48M

Avg Vol (3M)

$287.65K

Beta

0.84

Div Yield

-

BVS Company Profile


Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,030

IPO Date

Feb 11, 2021

Website

BVS Performance


Total Return %
1D
5D
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
BVS
S&P 500
-0.10%
-1.14%
3.69%
-7.38%
19.93%
-2.07%
128.79%
-13.18%
-45.81%
-45.81%
-0.00%
1.75%
2.03%
4.09%
9.99%
4.29%
22.74%
39.50%
81.06%
190.18%

Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 21
Restorative Therapies$121.57M
Pain Treatments$221.61M
Surgical Solutions$87.72M

Fiscal year ends in Dec 23 | Currency in USD

BVS Financial Summary


Dec 23Dec 22Dec 21
Revenue$512.35M$512.12M$430.90M
Operating Income$16.01M$-35.68M$17.72M
Net Income$-156.23M$-213.39M$9.59M
EBITDA$73.38M$31.13M$52.60M
Basic EPS$-2.49$-3.48$0.16
Diluted EPS$-2.49$-3.48$0.16

Fiscal year ends in Dec 23 | Currency in USD

Latest News


Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript

Nov 05, 24 | 12:26 PM | seekingalpha.com

Bioventus (BVS) Matches Q3 Earnings Estimates

Nov 05, 24 | 9:45 AM | zacks.com

Bioventus Reports Third Quarter Financial Results

Nov 05, 24 | 7:30 AM | globenewswire.com

Bull Of The Day: Bioventus (BVS)

Aug 29, 24 | 8:10 AM | zacks.com

Executives Buying W. P. Carey And 2 Other Stocks

Aug 21, 24 | 7:37 AM | benzinga.com

Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript

Aug 11, 24 | 1:45 PM | seekingalpha.com

Bioventus Reports Second Quarter Financial Results

Aug 06, 24 | 7:30 AM | globenewswire.com

3 Stocks Under $10 With Mammoth Growth Prospects

May 23, 24 | 6:42 AM | investorplace.com

Latest Sec Filing


4Feb 18, 25 | 6:00 PM
4Feb 18, 25 | 6:00 PM
4Feb 18, 25 | 5:59 PM
4Jan 14, 25 | 6:59 PM
4Jan 13, 25 | 5:24 PM
8-KJan 03, 25 | 4:09 PM
4Dec 26, 24 | 4:55 PM
4Dec 26, 24 | 4:55 PM
4Dec 26, 24 | 4:54 PM
4Dec 23, 24 | 5:28 PM
4Dec 23, 24 | 5:28 PM
4Dec 23, 24 | 5:27 PM
SCHEDULE 13G/ANov 14, 24 | 4:53 PM
SC 13G/ANov 08, 24 | 9:13 PM
10-QNov 05, 24 | 7:36 AM
8-KNov 05, 24 | 7:34 AM
424B3Nov 04, 24 | 4:28 PM
S-3Oct 25, 24 | 4:14 PM
8-KOct 04, 24 | 7:45 AM
4Aug 20, 24 | 6:16 PM
10-QAug 06, 24 | 7:51 AM
8-KAug 06, 24 | 7:40 AM
8-KJul 19, 24 | 4:16 PM
SC 13G/AJul 15, 24 | 5:15 PM
4Jun 25, 24 | 4:59 PM

Latest Earnings Call Transcripts


Q3 24Nov 05, 24 | 8:30 AM
Q2 24Aug 11, 24 | 8:03 AM
Q1 24May 07, 24 | 8:30 AM

Peer Comparison


TickerCompany
RPIDRapid Micro Biosystems, Inc.
NAOVNanoVibronix, Inc.
BBLGBone Biologics Corporation
VVOSVivos Therapeutics, Inc.
NUWENuwellis, Inc.
TIVCTivic Health Systems, Inc.
BJDXBluejay Diagnostics, Inc.
HSCSHeart Test Laboratories, Inc.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools